13 biotech companies to discover in the Swiss Health Valley in 2023
We recently featured BioAlps on the Beyond Biotech Podcast. While Basel is certainly a European…
We recently featured BioAlps on the Beyond Biotech Podcast. While Basel is certainly a European…
The guests on our podcast this week are: Jessica Robinson, project director, Advanced Therapies Congress,…
Companies specializing in the research and development of innovative cell and gene therapies continue to…
New cancer drugs are entering the market every year, but it’s hard to know which…
Aphaia Pharma is a Zug, Switzerland, headquartered clinical-stage biopharmaceutical company. It harnesses proprietary precision-targeted drug…
Araris Biotech AG is a Swiss-headquartered company pioneering the development of its novel antibody-drug-conjugate (ADC)-linker…
PDC*line Pharma, a clinical stage biotech company has announced the first immunological results of its…
MetrioPharm AG, a Swiss pharmaceutical company developing drugs for inflammatory diseases, has announced topline data…
Laevoroc Oncology, a privately-owned, Swiss oncology development company, has announced the publication of key preclinical…
Neuraxpharm Group, a European pharmaceutical company focused on the treatment of central nervous system (CNS)…
OmniSpirant Limited and EVerZom have launched INSPIRE, a €12.8 million ($13.4 million) lung cancer project…
Mutations of BRCA1 and BRCA2 genes, which are inherited by 1 in 400 and 1…